Respiratory Muscle Strength Training in Presbyphonia
1 other identifier
interventional
22
1 country
1
Brief Summary
Presbyphonia is an age-related voice disorder that affects more than 10 million people in the United States. Presbyphonia is characterized by vocal fold atrophy that impairs older individuals' ability to communicate, leading to social isolation and reduced quality of life. Outcomes from current treatment approaches are often suboptimal for patients with presbyphonia as they do not sufficiently challenge the respiratory system to induce meaningful change. It is highly likely that the addition of respiratory training would result in greatly improved outcomes, such as the ability to speak loud and long enough to have a normal conversation. The purpose of this study will be to examine the effect of adding inspiratory muscle strength training (IMST) or expiratory muscle strength training (EMST) to standard of care voice therapy on respiratory and voice outcomes in patients with an age-related voice disorder. Forty-eight participants diagnosed with presbyphonia will be blocked-randomized into three intervention groups, using a 3-parallel arm design: IMST and voice exercises, EMST and voice exercises, and voice exercises during all session. Study endpoints will be the change in voice and respiratory measures after four treatment sessions compared to baseline values. Response to treatment will be analyzed to determine if there are subgroups of high- or low-responders based on baseline voice and respiratory characteristics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2018
CompletedFirst Posted
Study publicly available on registry
June 15, 2018
CompletedStudy Start
First participant enrolled
June 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 16, 2019
CompletedResults Posted
Study results publicly available
September 7, 2020
CompletedSeptember 7, 2020
August 1, 2020
1 year
May 22, 2018
June 24, 2020
August 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Post-Treatment Mean in Voice Handicap Index Score
Voice Handicap Index-10 (ordinal scale that measures the degree of handicap a person experiences because of their voice disorder. Minimum score 0, maximal score 40. A lower score is better )
up to 5 weeks after baseline
Secondary Outcomes (16)
Post-treatment Mean in (Habitual) Sound Pressure Level
up to 5 weeks after baseline
Post-treatment Mean in Baseline Smoothed Cepstral Peak Prominence (CPPS) (During Reading)
up to 5 weeks after baseline
Post-treatment Mean in Baseline Noise-to-harmonic Ratio (NHR)
up to 5 weeks after baseline
Post-Treatment Mean in Baseline Amplitude Perturbation Quotient (APQ)
up to 5 weeks after baseline
Post-treatment Mean in Overall Severity of Voice Quality
up to 5 weeks after baseline
- +11 more secondary outcomes
Other Outcomes (1)
Voice-Vibratory Assessment With Laryngeal Imaging
up to 5 weeks after baseline
Study Arms (3)
Inspiratory Muscle Strength Training
EXPERIMENTALThe participants in the IMST arm will receive, in addition to standard of care voice therapy, inspiratory muscle strength training (IMST). The IMST intervention will consist of 5 sets of 5 breaths in the inspiratory threshold device every day during four weeks, with a loading dose set at 75% of the participants' maximal inspiratory pressure (MIP). MIP will be measured once a week during the weekly supervised session to adjust the inspiratory trainer.
Expiratory Muscle Strength Training
EXPERIMENTALThe participants in the EMST arm will receive, in addition to standard of care voice therapy, expiratory muscle strength training (EMST). The EMST intervention will consist of 5 sets of 5 breaths in the expiratory threshold device every day during four weeks, with a loading dose set at 75% of the participants' maximal expiratory pressure (MEP). MEP will be measured once a week during the weekly supervised session to adjust the inspiratory trainer.
Voice Exercises
ACTIVE COMPARATORThe participants in the voice exercises group will receive standard of care voice therapy with a speech language pathologist, once a week during four weeks, plus daily practices.
Interventions
IMST will be conducted using an inspiratory pressure threshold trainer (Philips Respironics® Threshold IMT or POWERbreathe® Medic Plus), which consists of a mouthpiece with a spring-loaded valve. The valve blocks the airflow until the threshold pressure is achieved by breathing in forcefully into the device. This allows airflow as long as the sufficient pressure is maintained.
EMST will be conducted using an expiratory pressure threshold trainer (EMST150®), which consists of a mouthpiece with a spring-loaded valve. The valve blocks the airflow until the threshold pressure is achieved by breathing out forcefully into the device. This allows airflow as long as the sufficient pressure is maintained.
Voice exercises will consist of the Vocal Function Exercises (VFE) protocol, developed by Stemple (2005). It contains 4 steps: (a) sustain the vowel /i/ on the musical note F for as long as possible. Repeat as judged by the SLP. (b) Glide from the lowest note to the highest note. Repeat as judged by the SLP. (c) Glide from the highest note to the lowest note. Repeat as judged by the SLP. (d) Sustain the notes C-D-E-F-G for as long as possible. Each note will be repeated until the participant finds the right placement (forward-focused voice), as judged by the SLP. Humming will be used to facilitate placement.
Eligibility Criteria
You may qualify if:
- must receive a diagnosis of presbyphonia by a trained laryngologist. The diagnosis will be given following a visual examination if the observations are consistent with the characteristics of a presbylarynx, as judged by the laryngologist.
- must be 50 years old and older.
You may not qualify if:
- has received voice therapy in the past year
- presents with a vocal fold pathology other than presbyphonia
- has a known neurologic or a progressive neuromuscular disease
- has a medical condition that could be aggravated by the experimental intervention, or any condition judged by the physician (Dr. Halstead) as being unsuitable for RMST.
- has dysarthria or a language disorder
- has a hearing loss that is not adequately managed
- has a cognitive disorder that might affect treatment compliance
- is unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29403, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Heather Shaw Bonilha
- Organization
- Medical University of South Carolina
Study Officials
- PRINCIPAL INVESTIGATOR
Heather Bonilha, PhD
Medical University of South Carolina
- STUDY DIRECTOR
Maude Desjardins, M.Sc.
Medical University of South Carolina
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Perceptual ratings of voice quality and of videostroboscopic images of the larynx will be rater by external judges, who will be blinded to the group assignment and to the assessment time (pre or post treatment).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2018
First Posted
June 15, 2018
Study Start
June 15, 2018
Primary Completion
June 25, 2019
Study Completion
July 16, 2019
Last Updated
September 7, 2020
Results First Posted
September 7, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share